[ClickPress, Fri Apr 19 2013] Global Markets Direct's, 'Cervical Dysplasia
- Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline.
at the University of North Carolina, Chapel Hill, and is director of the North Carolina Women's Hospital Cervical Dysplasia
vaginalis and Candidiasis with cervical dysplasia
in symptomatic Indian women.
(3) Therefore, colposcopy is also indicated for patients with symptoms suggestive of cervical dysplasia
or cancer (abnormal appearance of the cervix, or persistent and undiagnosed vaginal discharge or bleeding), even in the setting of normal cytology.
* Because of the potential for adverse obstetric complications following excisional procedures for cervical dysplasia
, gynecologists should closely adhere to the American Society for Colposcopy and Cervical Pathology guidelines when determining the appropriateness of dysplasia interventions.
The inclusion criteria were 20 to 60 years of age, HPV positive, no evidence of high-grade squamous intraepithelial lesions (HSIL) by Pap smear and colposcopy, no previous history of cervical dysplasia
or cancer, not pregnant, and HIV negative.
M2 EQUITYBITES-May 1, 2012-Inovio Pharmaceuticals Inc receives US patent protection for synthetic vaccine for cervical dysplasia
and cancer(C)2012 M2 COMMUNICATIONS http://www.m2.com
M2 PHARMA-October 22, 2010-Advaxis completes recruitment of first patient group in US cervical dysplasia
study(C)2010 M2 COMMUNICATIONS
Overall, CIN 2,3 was present in 35% of adolescent patients referred to colposcopy for cervical dysplasia
"Forty percent didn't come back for their second smear, which is a very high rate of non-compliance, and this is one of the factors that puts this group at high risk for cervical dysplasia
," she said.
* Further studies are needed to determine the most effective treatment for mild cervical dysplasia
and possible local effects of cryotherapy.
announced the initiation and opening of sites to enroll the second portion of the company's Phase 3 program for VGX-3100, Inovio's DNA-based immunotherapy to treat cervical dysplasia
caused by human papillomavirus (HPV).